Stay updated on Safety Tolerance Efficacy in IPF Clinical Trial
Sign up to get notified when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.

Latest updates to the Safety Tolerance Efficacy in IPF Clinical Trial page
- Check2 days agoChange DetectedThe page now displays a newer revision label, v3.5.4, replacing the previous v3.5.3. This indicates an internal site release or maintenance update rather than changes to study details or content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page revision label changed from v3.5.2 to v3.5.3, reflecting a minor internal update to the record. This does not alter the study details or public information presented.SummaryDifference0.1%

- Check23 days agoChange DetectedAdded a resource section linking to additional information about Idiopathic Pulmonary Fibrosis, including the Genetic and Rare Diseases Information Center.SummaryDifference0.2%

- Check30 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2. This appears to be a version-control update with no visible content changes to the page.SummaryDifference0.1%

- Check52 days agoChange DetectedThe page removes the 'Interstitial lung disease 2' item and the 'Genetic and Rare Diseases Information Center' resource. This could affect navigation and access to related information.SummaryDifference0.2%

- Check59 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0. This is a metadata version update and does not alter study data, eligibility criteria, locations, or results.SummaryDifference0.1%

Stay in the know with updates to Safety Tolerance Efficacy in IPF Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Safety Tolerance Efficacy in IPF Clinical Trial page.